Une candidature complète en une minute
Un CV et une lettre de motivation personnalisés, prêts à envoyer.
Seqirus is seeking an Associate Director, RWE Science to lead global real-world evidence programs across vaccine portfolios. You will shape RWE strategy within CORE, guiding study design, execution, and communications with regulatory and medical affairs teams.
Based in Amsterdam, with global collaboration, this senior role requires a track record in epidemiology, outcomes research, and leadership of large, cross-functional projects.
Associate Director (m/f/x), Real World Evidence (RWE) Science
Location: Amsterdam, Maidenhead, Munich
Join Seqirus and play a pivotal role in shaping the future of real-world evidence generation in vaccines. As Associate Director, RWE Science, you will be a senior scientific leader within the Center of Outcomes Research and Epidemiology (CORE), driving the development and execution of global real-world research strategies that support late-stage and marketed vaccine products. Working across a highly matrixed global environment, you will collaborate with Medical Affairs, R&D, Market Access, Regulatory Affairs, Commercial teams, and external scientific stakeholders to generate impactful evidence that informs clinical practice, supports health authority engagement, and strengthens public health outcomes worldwide.
Reporting to the Senior Director, Center of Outcomes Research and Epidemiology (CORE), you will provide scientific and methodological leadership for global real-world evidence programs and help shape the short- to medium-term RWE strategy.
To succeed in this role, you will bring strong scientific expertise, strategic thinking, and the ability to influence stakeholders across global functions.
At Seqirus, you'll have the opportunity to contribute to a global mission focused on protecting public health through innovative vaccine solutions. You'll work alongside highly experienced scientific and medical professionals in a collaborative environment that values innovation, development, and scientific excellence.
Join us in advancing science, improving patient outcomes, and helping protect communities worldwide.
CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state‑of‑the‑art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant tec